Intravenous thiamylal in pediatric sedation for MRI: A prospective observational study

Intravenous thiamylal in pediatric sedation for MRI: A prospective observational study - Intravenous thiamylal in pediatric sedation for MRI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026664

Enrollment

100

Registered

2017-04-01

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children who need sedation for MRI

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pediatric patients who requir sedation for MRI judged by their doctors with written consent for the participation of the study by their guardians.

Exclusion criteria

Exclusion criteria: 1. Patients with known allergy to barbiturates 2. Patients who have a fever over 38 degrees 3. Patients with acute respiratory infection 4. Patients who have underlying disease with airway abnormality 5. Class 3 or 4 in ASA-Physical status 6. Class 3 or 4 in Mallampati classification 7. Patients who administer medicine other than thiamylal during MRI examination 8. Previous participation of the study 9. Patients who are assessed inappropriate for the study judged by the doctor in charge

Design outcomes

Primary

Measure	Time frame
Success rate of MRI under sedation	—

Secondary

Measure	Time frame
Sedation related adverse events	—

Countries

Japan

Contacts

Public ContactShinji Irie

JAPANESE RED CROSS KUMAMOTO HOSPITAL Department of pediatrics

1.2.3.doooon@gmail.com096-384-2111

Outcome results